OVERVIEW OF COVID-19 CASES IN PREGNANCY AT THE HOSPITAL UNIVERSITAS SUMATERA UTARA, INDONESIA, WHEN THE PANDEMIC STORM HIT IN THE 2020-2022 PERIOD.

COVID-19 Cases In Pregnancy

Authors

  • Muhammad Ernesto Azguevara Ganis Siregar Universitas Sumatera Utara
  • Henry Salim Siregar Universitas Sumatera Utara
  • Muara Panusunan Lubis Universitas Sumatera Utara
  • Ichwanul Adenin Universitas Sumatera Utara
  • Irwin Lamtota Lumbanraja Universitas Sumatera Utara https://orcid.org/0000-0001-8437-1594

DOI:

https://doi.org/10.21010/Ajidv17i2S.4

Keywords:

Coronavirus 2019, fetomaternal outcomes, pregnancy, Severe Acute Respiratory Syndrome-Coronavirus-2

Abstract

Background: COVID-19 (Coronavirus 2019) is caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2), an acute infectious disease primarily affecting the respiratory system. Data on COVID-19 exposure during pregnancy and issues associated with COVID-19 during pregnancy remain limited. This research aimed to determine the number of pregnant women infected by COVID-19, laboratory test findings of pregnant women related to COVID-19 infection, infant outcome from mother with or without COVID-19 infection and referential status for COVID-19 and non-COVID-19 pregnant women at the USU Hospital during the 2020–2022 period.

Materials and Methods: This research was conducted using a descriptive method with a cross-sectional study approach using a non-probability sampling technique by collecting secondary data from COVID-19 and non-COVID-19 pregnant women at the USU Hospital during the 2020-2022 period, where 112 samples were obtained.

Results: The majority of COVID-19 pregnant women and non-COVID-19 pregnant women have been identified sequentially based on Hb (11.6%-decreased vs 79.5%-normal); Ht (11.6%-decreased vs 76.8%-increased); leukocytes (11.6%-increased vs 83%-normal); thrombocytes (8.9%-normal vs 86.6%-normal); PT (9.8%-normal vs 50.9%-normal); APTT (11.6%-normal vs 87.5%-normal); D-dimer (11.6%-long vs 56.3%-long); procalcitonin (7.1%-increased vs 87.5%-normal); NLR (8%-increased vs 82.1%-normal); CRP (12.5%-increased vs 87.5%-normal) and all of the baby outcomes were non-COVID-19 and the majority of pregnant women were not referred.

Conclusion: Based on the data in this study, the majority of pregnant women and babies at the USU Hospital during the 2020–2022 period were non-COVID-19 positive and with non-referral status. Laboratory findings of COVID-19 in pregnancy significantly reveals abnormalities.

References

Al‐Jarallah, M., Rajan, R., Saber, A. Al, Pan, J., Al‐Sultan, A.T., Abdelnaby, H., Alroomi, M., Dashti, R., Aboelhassan, W., Almutairi, F., Abdullah, M., Alotaibi, N., Saleh, M. Al, AlNasrallah, N., Al‐Bader, B., Malhas, H., Ramadhan, M., Hamza, M., Zhanna, K.D., (2021). In‐hospital mortality in SARS‐CoV‐2 stratified by hemoglobin levels: A retrospective study. EJHaem 2, 335–339. https://doi.org/10.1002/jha2.195.

Allotey, J., Fernandez, S., Bonet, M., Stallings, E., Yap, M., Kew, T., Zhou, D., Coomar, D., Sheikh, J., Lawson, H., Ansari, K., Attarde, S., Littmoden, M., Banjoko, A., Barry, K., Akande, O., Sambamoorthi, D., van Wely, M., van Leeuwen, E., Kostova, E., Kunst, H., Khalil, A., Tiberi, S., Brizuela, V., Broutet, N., Kara, E., Kim, C.R., Thorson, A., Escuriet, R., Gottlieb, S., Tong, V.T., Ellington, S., Oladapo, O.T., Mofenson, L., Zamora, J., Thangaratinam, S., (2020). Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ m3320. https://doi.org/10.1136/bmj.m3320.

Bonnesen, B., Jensen, J.-U.S., Jeschke, K.N., Mathioudakis, A.G., Corlateanu, A., Hansen, E.F., Weinreich, U.M., Hilberg, O., Sivapalan, P., (2021). Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation. Diagnostics 11, 2259. https://doi.org/10.3390/diagnostics11122259.

Covali, R., Socolov, D., Socolov, R., Pavaleanu, I., Carauleanu, A., Akad, M., Boiculese, V.L., Adam, A.M., (2021). Complete Blood Count Peculiarities in Pregnant SARS-CoV-2-Infected Patients at Term: A Cohort Study. Diagnostics 12, 80. https://doi.org/10.3390/diagnostics12010080.

Dumitriu, D., Emeruwa, U.N., Hanft, E., Liao, G. V., Ludwig, E., Walzer, L., Arditi, B., Saslaw, M., Andrikopoulou, M., Scripps, T., Baptiste, C., Khan, A., Breslin, N., Rubenstein, D., Simpson, L.L., Kyle, M.H., Friedman, A.M., Hirsch, D.S., Miller, R.S., Fernández, C.R., Fuchs, K.M., Keown, M.K., Glassman, M.E., Stephens, A., Gupta, A., Sultan, S., Sibblies, C., Whittier, S., Abreu, W., Akita, F., Penn, A., D’Alton, M.E., Orange, J.S., Goffman, D., Saiman, L., Stockwell, M.S., Gyamfi-Bannerman, C., (2021). Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City. JAMA Pediatr 175, 157. https://doi.org/10.1001/jamapediatrics.2020.4298.

Lagunas‐Rangel, F.A., (2020). Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis. J Med Virol 92, 1733–1734. https://doi.org/10.1002/jmv.25819.

Levi, M., Thachil, J., Iba, T., Levy, J.H., (2020). Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 7, e438–e440. https://doi.org/10.1016/S2352-3026(20)30145-9.

Liu, H., Wang, L.-L., Zhao, S.-J., Kwak-Kim, J., Mor, G., Liao, A.-H., (2020). Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol 139, 103122. https://doi.org/10.1016/j.jri.2020.103122.

LUMBANRAJA, S., EFFENDI, I.H., SIAHAAN, A.M., BANCIN, B.E.P., EDIANTO, D., ASROEL, E.M., SUDEWO, Y., (2023). CORRELATION OF SARS-COV-2 EXPRESSION IN THE PLACENTA AND THE INCIDENCE OF PREECLAMPSIA. African Journal of Infectious Diseases 17, 45–54. https://doi.org/10.21010/Ajidv17i1.4.

Marsden, K.A., Ten Eyck, P.P., Maxwell, T.N., Castaneda, C.N., Kenne, K.A., Swartz, S.R., Steffen, H.A., Merrill, A.E., Krasowski, M.D., Merryman, A.S., Jackson, J.B., Rysavy, M.B., (2021). COVID-19 Infection and Disease Severity not associated with Increased Parity among Pregnant Women. Journal of Medical – Clinical Research & Reviews 5. https://doi.org/10.33425/2639-944X.1214.

Metz, T.D., Clifton, R.G., Hughes, B.L., Sandoval, G., Saade, G.R., Grobman, W.A., Manuck, T.A., Miodovnik, M., Sowles, A., Clark, K., Gyamfi-Bannerman, C., Mendez-Figueroa, H., Sehdev, H.M., Rouse, D.J., Tita, A.T.N., Bailit, J., Costantine, M.M., Simhan, H.N., Macones, G.A., (2021). Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstetrics & Gynecology 137, 571–580. https://doi.org/10.1097/AOG.0000000000004339.

Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of Pathology & Laboratory Medicine. (2020). [DOI:10.5858/arpa.2020-0901-SA] [PMID].

Nowakowski, F., Krajewska, K., Klimek, K., Wierzba, W., Jakimiuk, A.J., (2021). COVID-19 during pregnancy one year on — what lessons did we learn? Ginekol Pol 92, 383–386. https://doi.org/10.5603/GP.a2021.0095

Parisa Maleki Dana, Fariba Kolahdooz, Fatemeh Sadoughi, (2020). Covid-19 and Pregnancy : a Review of Current Knowledge. Infez Med.

Pereira, A., Cruz‐Melguizo, S., Adrien, M., Fuentes, L., Marin, E., Perez‐Medina, T., (2020). Clinical course of coronavirus disease‐2019 in pregnancy. Acta Obstet Gynecol Scand 99, 839–847. https://doi.org/10.1111/aogs.13921

Rasmussen, S.A., Smulian, J.C., Lednicky, J.A., Wen, T.S., Jamieson, D.J., (2020). Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 222, 415–426. https://doi.org/10.1016/j.ajog.2020.02.017

Royal College of Obstetricians and Gynaecologists, (2020). Coronavirus (COVID-19) infection in pregnancy. Information for health care professional.

Satgas Penanganan COVID-19, (2020). Satgas Penanganan COVID-19 [WWW Document].

Satuan Tugas Penanganan, (2022). Covid 19 [WWW Document]. Pusdatin Kementerian Kesehatan RI.

Semaan, A., Banke-Thomas, A., Amongin, D., Babah, O., Dioubate, N., Kikula, A., Nakubulwa, S., Ogein, O., Adroma, M., Anzo Adiga, W., Diallo, A., Diallo, L., Cellou Diallo, M., Maomou, C., Mtinangi, N., Sy, T., Delvaux, T., Afolabi, B.B., Delamou, A., Nakimuli, A., Pembe, A.B., Benova, L., (2022). ‘We are not going to shut down, because we cannot postpone pregnancy’: a mixed-methods study of the provision of maternal healthcare in six referral maternity wards in four sub-Saharan African countries during the COVID-19 pandemic. BMJ Glob Health 7, e008063. https://doi.org/10.1136/bmjgh-2021-008063

Siregar, M.F.G., Siregar, E.K.H., (2021). The Effect of Coronavirus Disease 2019 on Reproduction System and Fertility. Open Access Maced J Med Sci 9, 362–368. https://doi.org/10.3889/oamjms.2021.6346

Soheili, Marzieh, Moradi, G., Baradaran, H.R., Soheili, Maryam, Mokhtari, M.M., Moradi, Y., (2022). Clinical manifestation and maternal complications and neonatal outcomes in pregnant women with COVID-19: a comprehensive evidence synthesis and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 35, 5672–5685. https://doi.org/10.1080/14767058.2021.1888923

Stanley, K.E., Thomas, E., Leaver, M., Wells, D., (2020). Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril 114, 33–43. https://doi.org/10.1016/j.fertnstert.2020.05.001

Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T.N., Politou, M., Psaltopoulou, T., Gerotziafas, G., Dimopoulos, M.A., (2020). Hematological findings and complications of COVID‐19. Am J Hematol 95, 834–847. https://doi.org/10.1002/ajh.25829

Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., Iba, T., (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis 18, 1023–1026. https://doi.org/10.1111/jth.14810

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z., (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 323, 1061. https://doi.org/10.1001/jama.2020.1585

Wastnedge, E.A.N., Reynolds, R.M., van Boeckel, S.R., Stock, S.J., Denison, F.C., Maybin, J.A., Critchley, H.O.D., (2021). Pregnancy and COVID-19. Physiol Rev 101, 303–318. https://doi.org/10.1152/physrev.00024.2020

World Health Organization, 2022. Situation Report – 42 .

Wróblewska-Seniuk, K., Basiukajć, A., Wojciechowska, D., Telge, M., Miechowicz, I., Mazela, J., (2021). Clinical Characteristics of Newborns Born to Mothers with COVID-19. J Clin Med 10, 4383. https://doi.org/10.3390/jcm10194383

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., Zhou, Y., (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases 94, 91–95. https://doi.org/10.1016/j.ijid.2020.03.017

Downloads

Published

2023-08-01

How to Cite

Siregar, M. E. A. G., Siregar, H. S., Lubis, M. P., Adenin, I., & Lumbanraja, I. L. (2023). OVERVIEW OF COVID-19 CASES IN PREGNANCY AT THE HOSPITAL UNIVERSITAS SUMATERA UTARA, INDONESIA, WHEN THE PANDEMIC STORM HIT IN THE 2020-2022 PERIOD. : COVID-19 Cases In Pregnancy . African Journal of Infectious Diseases (AJID), 17(2 S), 19–24. https://doi.org/10.21010/Ajidv17i2S.4